Privia Health initiated with a Buy at Stifel

Stifel analyst Craig Jones initiated coverage of Privia Health with a Buy rating and $28 price target. Privia provides a platform for provider groups to transition from FFS healthcare to value based care "at their preferred pace," said Jones, who calls it a "low-risk value based care play already generating cash." He thinks Privia "should compound revenue high teens+ with expanding margins," the analyst added.